Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Neuroprotection after cerebral ischemia.

Namura S, Ooboshi H, Liu J, Yenari MA.

Ann N Y Acad Sci. 2013 Mar;1278:25-32. doi: 10.1111/nyas.12087.

3.

Chronic treatment with fibrates elevates superoxide dismutase in adult mouse brain microvessels.

Wang G, Liu X, Guo Q, Namura S.

Brain Res. 2010 Nov 4;1359:247-55. doi: 10.1016/j.brainres.2010.08.075. Epub 2010 Sep 21.

4.

Vaticanol C, a resveratrol tetramer, activates PPARalpha and PPARbeta/delta in vitro and in vivo.

Tsukamoto T, Nakata R, Tamura E, Kosuge Y, Kariya A, Katsukawa M, Mishima S, Ito T, Iinuma M, Akao Y, Nozawa Y, Arai Y, Namura S, Inoue H.

Nutr Metab (Lond). 2010 May 27;7:46. doi: 10.1186/1743-7075-7-46.

5.

Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice.

Guo Q, Wang G, Namura S.

J Cereb Blood Flow Metab. 2010 Jan;30(1):70-8. doi: 10.1038/jcbfm.2009.185. Epub 2009 Sep 2. Erratum in: J Cereb Blood Flow Metab. 2010 Jan;30(1):242. Dosage error in article text.

6.

Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice.

Wang G, Guo Q, Hossain M, Fazio V, Zeynalov E, Janigro D, Mayberg MR, Namura S.

Brain Res. 2009 Oct 19;1294:183-92. doi: 10.1016/j.brainres.2009.07.070. Epub 2009 Jul 29.

7.

Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice.

Guo Q, Wang G, Liu X, Namura S.

Brain Res. 2009 Jul 7;1279:121-30. doi: 10.1016/j.brainres.2009.04.055. Epub 2009 May 7.

8.

Filamentous middle cerebral artery occlusion causes ischemic damage to the retina in mice.

Steele EC Jr, Guo Q, Namura S.

Stroke. 2008 Jul;39(7):2099-104. doi: 10.1161/STROKEAHA.107.504357. Epub 2008 Apr 24.

9.

Brain protection by resveratrol and fenofibrate against stroke requires peroxisome proliferator-activated receptor alpha in mice.

Inoue H, Jiang XF, Katayama T, Osada S, Umesono K, Namura S.

Neurosci Lett. 2003 Dec 11;352(3):203-6.

PMID:
14625020
10.

Relationship between expression of multiple drug resistance proteins and p53 tumor suppressor gene proteins in human brain astrocytes.

Marroni M, Agrawal ML, Kight K, Hallene KL, Hossain M, Cucullo L, Signorelli K, Namura S, Bingaman W, Janigro D.

Neuroscience. 2003;121(3):605-17.

PMID:
14568021
11.

Blood-brain barrier damage induces release of alpha2-macroglobulin.

Cucullo L, Marchi N, Marroni M, Fazio V, Namura S, Janigro D.

Mol Cell Proteomics. 2003 Apr;2(4):234-41. Epub 2003 Apr 24.

12.

The HD mutation does not alter neuronal death in the striatum of Hdh(Q92) knock-in mice after mild focal ischemia.

Namura S, Hirt L, Wheeler VC, McGinnis KM, Hilditch-Maguire P, Moskowitz MA, MacDonald ME, Persichetti F.

Neurobiol Dis. 2002 Oct;11(1):147-54.

PMID:
12460554
13.

TAK-779, a nonpeptide CC chemokine receptor antagonist, protects the brain against focal cerebral ischemia in mice.

Takami S, Minami M, Katayama T, Nagata I, Namura S, Satoh M.

J Cereb Blood Flow Metab. 2002 Jul;22(7):780-4.

14.

Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice.

Namura S, Maeno H, Takami S, Jiang XF, Kamichi S, Wada K, Nagata I.

Neurosci Lett. 2002 May 17;324(2):117-20.

PMID:
11988341
15.

Chemokine receptor antagonist peptide, viral MIP-II, protects the brain against focal cerebral ischemia in mice.

Takami S, Minami M, Nagata I, Namura S, Satoh M.

J Cereb Blood Flow Metab. 2001 Dec;21(12):1430-5.

16.

The AMPA receptor allosteric potentiator PEPA ameliorates post-ischemic memory impairment.

Sekiguchi M, Yamada K, Jin J, Hachitanda M, Murata Y, Namura S, Kamichi S, Kimura I, Wada K.

Neuroreport. 2001 Sep 17;12(13):2947-50.

PMID:
11588608
17.

Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia.

Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11569-74. Epub 2001 Aug 14.

18.
19.
20.

Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins.

Satoh T, Furuta K, Tomokiyo K, Namura S, Nakatsuka D, Sugie Y, Ishikawa Y, Hatanaka H, Suzuki M, Watanabe Y.

J Neurochem. 2001 Apr;77(1):50-62.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk